Blue Owl Capital (OWL) is facing renewed market pressure after telling investors they’ll have to wait to pull money from one of its longstanding private credit vehicles. The stock slid nearly 6% on ...

Learn how industrial data flows have fundamentally changed with edge computing and cloud connectivity, where sensor data can now bypass traditional hierarchical structures to go directly from Level 0 ...

All 50 states as well as the District of Columbia and U.S. territories have approved a $7.4 billion settlement with Purdue Pharma, maker of Oxycontin, over the company's improper marketing of opioids.

The 2024 Old Oaken Bucket game between Indiana and Purdue is upon us. IU and Purdue are coming off losses last week, but that's where the similarities end. The Hoosiers are No. 10 in the US LBM ...

Makuochi Echebiri is a News Writer for Collider. He has been interested in creative writing from as far back as high school, and he would consume pretty much anything that’s film or TV. However, his ...

For over 30 years, thousands of scavenger hunters have been in hot pursuit of a bronze statuette of an owl. The parties who carefully placed the artifact and issued clues as to its location have ...

IPI, which invests in data centers, marks OWL's fourth buy this year Deal adds about $10.5 bln in assets to OWL's kitty OWL expanding into growing data center market Oct 7 (Reuters) - Blue Owl (OWL.N) ...

A decades-long treasure hunt for a golden owl statuette in France finally came to an end after 31 years on Thursday. The treasure—a replica of the original golden owl statuette, which is made of gold, ...

Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Nothing has been set in stone regarding the return of this trio of beloved animated shows, though ...

Research-integrity watchers are concerned about the growing ways in which scientists can fake or manipulate the citation counts of their studies. In recent months, increasingly bold practices have ...

Purdue Pharma, the company best known for fueling the opioid crisis by misleadingly marketing the infamous painkiller OxyContin, received approval on Wednesday for a new auto-injector device used to ...